193 related articles for article (PubMed ID: 21701587)
1. Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells.
Hau PM; Tsang CM; Yip YL; Huen MS; Tsao SW
PLoS One; 2011; 6(6):e21176. PubMed ID: 21701587
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.
Li HM; Zhuang ZH; Wang Q; Pang JC; Wang XH; Wong HL; Feng HC; Jin DY; Ling MT; Wong YC; Eliopoulos AG; Young LS; Huang DP; Tsao SW
Oncogene; 2004 May; 23(25):4488-94. PubMed ID: 15064751
[TBL] [Abstract][Full Text] [Related]
4. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
5. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
6. Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells.
Sung WW; Chu YC; Chen PR; Liao MH; Lee JW
Cancer Lett; 2016 Nov; 382(1):21-31. PubMed ID: 27567526
[TBL] [Abstract][Full Text] [Related]
7. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
Yang GD; Huang TJ; Peng LX; Yang CF; Liu RY; Huang HB; Chu QQ; Yang HJ; Huang JL; Zhu ZY; Qian CN; Huang BJ
PLoS One; 2013; 8(10):e78355. PubMed ID: 24194922
[TBL] [Abstract][Full Text] [Related]
9. Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.
Shi F; He Y; Li J; Tang M; Li Y; Xie L; Zhao L; Hu J; Luo X; Zhou M; Liu N; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Jia W; Bode AM; Cao Y
Mol Metab; 2020 Jun; 36():100966. PubMed ID: 32224436
[TBL] [Abstract][Full Text] [Related]
10. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
[TBL] [Abstract][Full Text] [Related]
11. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
[TBL] [Abstract][Full Text] [Related]
12. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.
Lo AK; Dawson CW; Young LS; Ko CW; Hau PM; Lo KW
J Pathol; 2015 Oct; 237(2):238-48. PubMed ID: 26096068
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells.
Liu HP; Chen CC; Wu CC; Huang YC; Liu SC; Liang Y; Chang KP; Chang YS
PLoS Pathog; 2012; 8(5):e1002690. PubMed ID: 22589722
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
[TBL] [Abstract][Full Text] [Related]
15. EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy.
Fang W; Zhang J; Hong S; Zhan J; Chen N; Qin T; Tang Y; Zhang Y; Kang S; Zhou T; Wu X; Liang W; Hu Z; Ma Y; Zhao Y; Tian Y; Yang Y; Xue C; Yan Y; Hou X; Huang P; Huang Y; Zhao H; Zhang L
Oncotarget; 2014 Dec; 5(23):12189-202. PubMed ID: 25361008
[TBL] [Abstract][Full Text] [Related]
16. EBV-encoded LMP1 increases nuclear β-catenin accumulation and its transcriptional activity in nasopharyngeal carcinoma.
You S; Zhang F; Meng F; Li H; Liu Q; Liang Y; Dong Y; Yang W; Han A
Tumour Biol; 2011 Aug; 32(4):623-30. PubMed ID: 21336584
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
18. LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma.
Cai TT; Ye SB; Liu YN; He J; Chen QY; Mai HQ; Zhang CX; Cui J; Zhang XS; Busson P; Zeng YX; Li J
PLoS Pathog; 2017 Jul; 13(7):e1006503. PubMed ID: 28732079
[TBL] [Abstract][Full Text] [Related]
19. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
Tao Y; Shi Y; Jia J; Jiang Y; Yang L; Cao Y
Expert Rev Mol Med; 2015 Aug; 17():e15. PubMed ID: 26282825
[TBL] [Abstract][Full Text] [Related]
20. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]